| Kent/sussex Community Mental Health Center | |
|
805 River Rd Dover DE 19901-3753 | |
| (302) 739-4275 | |
| Not Available |
| Full Name | Kent/sussex Community Mental Health Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 805 River Rd, Dover, Delaware |
| Authorized Official Name and Position | Stanley J Kotula (MEDICAL DIRECTOR/DIRECTOR OF CLINIC) |
| Authorized Official Contact | 3025766093 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Kent/sussex Community Mental Health Center 10 Sw Front St Milford DE 19963-1948 Ph: (302) 422-1422 | Kent/sussex Community Mental Health Center 805 River Rd Dover DE 19901-3753 Ph: (302) 739-4275 |
| NPI Number | 1104871920 |
|---|---|
| Provider Enumeration Date | 05/23/2006 |
| Last Update Date | 02/25/2020 |
| Certification Date | 02/25/2020 |
| Medicare PECOS PAC ID | 6507756731 |
|---|---|
| Medicare Enrollment ID | O20040319000575 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.
Like the "golden hour" of trauma care that increases the odds of a person's survival, some clinicians are now applying that philosophy to the treatment of schizophrenia, one of the most puzzling mental health disorders.
Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.
A new health study that accounts for "acquired immunity" when evaluating the risk of microbial illness from food or environmental exposures suggests that some current approaches may significantly overestimate their role in causing such illnesses.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104871920 | NPI | - | NPPES |
| 0000609824 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
| Provider Name | Duane D Shubert |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1639128465 PECOS PAC ID: 0446140354 Enrollment ID: I20040316000938 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.
Like the "golden hour" of trauma care that increases the odds of a person's survival, some clinicians are now applying that philosophy to the treatment of schizophrenia, one of the most puzzling mental health disorders.
Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.
A new health study that accounts for "acquired immunity" when evaluating the risk of microbial illness from food or environmental exposures suggests that some current approaches may significantly overestimate their role in causing such illnesses.
› Verified 6 days ago
| Provider Name | Rick Hong |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1851379473 PECOS PAC ID: 2961471461 Enrollment ID: I20040930001074 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.
Like the "golden hour" of trauma care that increases the odds of a person's survival, some clinicians are now applying that philosophy to the treatment of schizophrenia, one of the most puzzling mental health disorders.
Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.
A new health study that accounts for "acquired immunity" when evaluating the risk of microbial illness from food or environmental exposures suggests that some current approaches may significantly overestimate their role in causing such illnesses.
› Verified 6 days ago
| Provider Name | Andrew W Donohue |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1346237559 PECOS PAC ID: 2567434269 Enrollment ID: I20060223000123 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.
Like the "golden hour" of trauma care that increases the odds of a person's survival, some clinicians are now applying that philosophy to the treatment of schizophrenia, one of the most puzzling mental health disorders.
Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.
A new health study that accounts for "acquired immunity" when evaluating the risk of microbial illness from food or environmental exposures suggests that some current approaches may significantly overestimate their role in causing such illnesses.
› Verified 6 days ago
| Provider Name | Fawzia K Hasan |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1467506915 PECOS PAC ID: 3274639802 Enrollment ID: I20070427000463 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.
Like the "golden hour" of trauma care that increases the odds of a person's survival, some clinicians are now applying that philosophy to the treatment of schizophrenia, one of the most puzzling mental health disorders.
Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.
A new health study that accounts for "acquired immunity" when evaluating the risk of microbial illness from food or environmental exposures suggests that some current approaches may significantly overestimate their role in causing such illnesses.
› Verified 6 days ago
| Provider Name | Eric W Schwarz |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1053398461 PECOS PAC ID: 2163500042 Enrollment ID: I20080417000108 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.
Like the "golden hour" of trauma care that increases the odds of a person's survival, some clinicians are now applying that philosophy to the treatment of schizophrenia, one of the most puzzling mental health disorders.
Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.
A new health study that accounts for "acquired immunity" when evaluating the risk of microbial illness from food or environmental exposures suggests that some current approaches may significantly overestimate their role in causing such illnesses.
› Verified 6 days ago
| Provider Name | Stephen J Kushner |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1134104805 PECOS PAC ID: 1355438037 Enrollment ID: I20080516000119 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.
Like the "golden hour" of trauma care that increases the odds of a person's survival, some clinicians are now applying that philosophy to the treatment of schizophrenia, one of the most puzzling mental health disorders.
Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.
A new health study that accounts for "acquired immunity" when evaluating the risk of microbial illness from food or environmental exposures suggests that some current approaches may significantly overestimate their role in causing such illnesses.
› Verified 6 days ago
| Provider Name | Mohammad Haque |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1063424539 PECOS PAC ID: 8224111448 Enrollment ID: I20131127000186 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.
Like the "golden hour" of trauma care that increases the odds of a person's survival, some clinicians are now applying that philosophy to the treatment of schizophrenia, one of the most puzzling mental health disorders.
Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.
A new health study that accounts for "acquired immunity" when evaluating the risk of microbial illness from food or environmental exposures suggests that some current approaches may significantly overestimate their role in causing such illnesses.
› Verified 6 days ago
| Provider Name | Reinette N Charles |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518365360 PECOS PAC ID: 8022339225 Enrollment ID: I20150529002256 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.
Like the "golden hour" of trauma care that increases the odds of a person's survival, some clinicians are now applying that philosophy to the treatment of schizophrenia, one of the most puzzling mental health disorders.
Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.
A new health study that accounts for "acquired immunity" when evaluating the risk of microbial illness from food or environmental exposures suggests that some current approaches may significantly overestimate their role in causing such illnesses.
› Verified 6 days ago
| Provider Name | Curtis Harris |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1033134234 PECOS PAC ID: 9335103928 Enrollment ID: I20161026003000 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.
Like the "golden hour" of trauma care that increases the odds of a person's survival, some clinicians are now applying that philosophy to the treatment of schizophrenia, one of the most puzzling mental health disorders.
Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.
A new health study that accounts for "acquired immunity" when evaluating the risk of microbial illness from food or environmental exposures suggests that some current approaches may significantly overestimate their role in causing such illnesses.
› Verified 6 days ago
| Provider Name | Vedette Bond |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1326635194 PECOS PAC ID: 0941607261 Enrollment ID: I20210929000020 |
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.
Like the "golden hour" of trauma care that increases the odds of a person's survival, some clinicians are now applying that philosophy to the treatment of schizophrenia, one of the most puzzling mental health disorders.
Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.
A new health study that accounts for "acquired immunity" when evaluating the risk of microbial illness from food or environmental exposures suggests that some current approaches may significantly overestimate their role in causing such illnesses.
› Verified 6 days ago
News Archive
Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today reported milestone achievements advancing BiovaxID, Biovest's personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma, including a recently conducted regulatory meeting with the European Medicines Agency (EMA) and the appointment of a key contributor to the Human Genome Project to its Scientific Advisory Board.
Like the "golden hour" of trauma care that increases the odds of a person's survival, some clinicians are now applying that philosophy to the treatment of schizophrenia, one of the most puzzling mental health disorders.
Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.
A new health study that accounts for "acquired immunity" when evaluating the risk of microbial illness from food or environmental exposures suggests that some current approaches may significantly overestimate their role in causing such illnesses.
› Verified 6 days ago
Northnode Group Counseling Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1609 S State St, Dover, DE 19901 Phone: 302-257-3135 Fax: 302-526-2410 | |
I & K Quality Health Care Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 229 Jordan Dr, Dover, DE 19904 Phone: 303-674-5259 | |
Goodnights Counseling Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 725 Walker Rd, Dover, DE 19904 Phone: 302-270-3906 | |
Indigo Wellness, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 144 Kings Hwy Ste 302, Dover, DE 19901 Phone: 302-450-3936 Fax: 302-450-3927 | |
Kent Sussex Counseling Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1241 College Park Dr, Dover, DE 19904 Phone: 302-735-7790 Fax: 302-735-3654 | |
Embracing Oak Therapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 9 E Loockerman St Ste 302, Dover, DE 19901 Phone: 412-953-2791 | |
A Center For Mental Wellness Community Support Programs, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 121 W Loockerman St, Dover, DE 19904 Phone: 302-674-1397 Fax: 302-674-1602 |